This inventor holds 2 USPTO granted patents. Top assignees: Hovione Scienta Limited, Hovione Scientia Limited. Active years: 2018-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018-2020
Title: Ana Carina Constantino: Innovator in Pharmaceutical Chemistry
Introduction
Ana Carina Constantino is a notable inventor based in Charneca da Caparica, Portugal. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of aclidinium bromide. With a total of 2 patents, her work exemplifies innovation in drug formulation and preparation.
Latest Patents
Ana's latest patents focus on the process for the preparation of aclidinium bromide. This process involves reacting 2-hydroxy-2,2-dithien-2-ylacetic acid 1-azabicyclo[2.2.2]oct-3(R) yl methyl ester with 3-phenoxypropyl bromide. The reaction occurs in a solvent or mixture of solvents selected from the group of amides and/or solvents with a sulfoxide group. Additionally, her patent describes a crystalline form of aclidinium bromide characterized by a specific powder XRPD pattern, which includes peaks at various angles. A pharmaceutical composition that includes aclidinium bromide and a pharmaceutically acceptable excipient is also part of her innovative work.
Career Highlights
Throughout her career, Ana Carina Constantino has worked with reputable companies such as Hovione Scientia Limited and Hovione Scienta Limited. Her experience in these organizations has contributed to her expertise in pharmaceutical development and innovation.
Collaborations
Ana has collaborated with talented individuals in her field, including Zita Mendes and Constança Cacela. These collaborations have likely enriched her research and development efforts.
Conclusion
Ana Carina Constantino stands out as an influential inventor in the pharmaceutical industry, with her innovative work on aclidinium bromide paving the way for advancements in drug formulation. Her contributions reflect a commitment to improving healthcare through scientific innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile